Literature DB >> 17982488

Wild-type p53 and p73 negatively regulate expression of proliferation related genes.

M J Scian1, E H Carchman, L Mohanraj, K E R Stagliano, M A E Anderson, D Deb, B M Crane, T Kiyono, B Windle, S P Deb, S Deb.   

Abstract

When normal cells come under stress, the wild-type (WT) p53 level increases resulting in the regulation of gene expression responsible for growth arrest or apoptosis. Here we show that elevated levels of WT p53 or its homologue, p73, inhibit expression of a number of cell cycle regulatory and growth promoting genes. Our analysis also identified a group of genes whose expression is differentially regulated by WT p53 and p73. We have infected p53-null H1299 human lung carcinoma cells with recombinant adenoviruses expressing WT p53, p73 or beta-galactosidase, and have undertaken microarray hybridization analyses to identify genes whose expression profile is altered by p53 or p73. Quantitative real-time PCR verified the repression of E2F-5, centromere protein A and E, minichromosome maintenance proteins (MCM)-2, -3, -5, -6 and -7 and human CDC25B after p53 expression. 5-Fluorouracil treatment of colon carcinoma HCT116 cells expressing WT p53 results in a reduction of the cyclin B2 protein level suggesting that DNA damage may indeed cause repression of these genes. Transient transcriptional assays verified that WT p53 repressed promoters of a number of these genes. Interestingly, a gain-of-function p53 mutant instead upregulated a number of these promoters in transient transfection. Using promoter deletion mutants of MCM-7 we have found that WT p53-mediated repression needs a minimal promoter that contains a single E2F site and surrounding sequences. However, a single E2F site cannot be significantly repressed by WT p53. Many of the genes identified are also repressed by p21. Thus, our work shows that WT p53 and p73 repress a number of growth-related genes and that in many instances this repression may be through the induction of p21.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17982488     DOI: 10.1038/sj.onc.1210898

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  31 in total

1.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

2.  Loss of p73 promotes dissemination of Myc-induced B cell lymphomas in mice.

Authors:  Alice Nemajerova; Oleksi Petrenko; Lorenz Trümper; Gustavo Palacios; Ute M Moll
Journal:  J Clin Invest       Date:  2010-05-17       Impact factor: 14.808

3.  A reduction of licensed origins reveals strain-specific replication dynamics in mice.

Authors:  Tsuyoshi Kawabata; Satoru Yamaguchi; Tavanna Buske; Spencer W Luebben; Marsha Wallace; Ilze Matise; John C Schimenti; Naoko Shima
Journal:  Mamm Genome       Date:  2011-05-25       Impact factor: 2.957

Review 4.  Clinical implications of the deregulated TP73 isoforms expression in cancer.

Authors:  N Rodríguez; A Peláez; R Barderas; G Domínguez
Journal:  Clin Transl Oncol       Date:  2017-12-11       Impact factor: 3.405

5.  Dose- and time-dependent expression patterns of zebrafish orthologs of selected E2F target genes in response to serum starvation/replenishment.

Authors:  Ceren Sucularli; Serif Senturk; Mehmet Ozturk; Ozlen Konu
Journal:  Mol Biol Rep       Date:  2010-11-30       Impact factor: 2.316

6.  PIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancer.

Authors:  Austin N Kirschner; Jie Wang; Riet van der Meer; Philip D Anderson; Omar E Franco-Coronel; Max H Kushner; Joel H Everett; Omar Hameed; Erika K Keeton; Miika Ahdesmaki; Shaun E Grosskurth; Dennis Huszar; Sarki A Abdulkadir
Journal:  J Natl Cancer Inst       Date:  2014-12-13       Impact factor: 13.506

7.  Unscheduled expression of CDC25B in S-phase leads to replicative stress and DNA damage.

Authors:  Béatrix Bugler; Estelle Schmitt; Bernadette Aressy; Bernard Ducommun
Journal:  Mol Cancer       Date:  2010-02-04       Impact factor: 27.401

8.  Codon 104 variation of p53 gene provides adaptive apoptotic responses to extreme environments in mammals of the Tibet plateau.

Authors:  Yang Zhao; Ji-Long Ren; Ming-Yang Wang; Sheng-Ting Zhang; Yu Liu; Min Li; Yi-Bin Cao; Hu-Yue Zu; Xiao-Cheng Chen; Chung-I Wu; Eviatar Nevo; Xue-Qun Chen; Ji-Zeng Du
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

9.  Udu deficiency activates DNA damage checkpoint.

Authors:  Chiaw-Hwee Lim; Shang-Wei Chong; Yun-Jin Jiang
Journal:  Mol Biol Cell       Date:  2009-08-05       Impact factor: 4.138

10.  Alterations in gene expression and sensitivity to genotoxic stress following HdmX or Hdm2 knockdown in human tumor cells harboring wild-type p53.

Authors:  Katherine Heminger; Michael Markey; Meldrick Mpagi; Steven J Berberich
Journal:  Aging (Albany NY)       Date:  2009-01       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.